| Financial Year |
March 31 2023 |
| Monetary Funds |
1,773,074,902.95 |
| Held-for-trading Financial Assets |
1,100,000,000.00 |
| Notes Receivable |
23,646,991.71 |
| Accounts Receivable |
1,289,080,909.70 |
| Advances to Suppliers |
32,373,988.08 |
| Other Receivables |
15,763,889.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
107,897,164.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
94,505,341.55 |
| Total Current Assets |
4,525,145,461.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
585,260,872.67 |
| Investment Properties |
93,877,948.45 |
| Fixed Assetes |
4,221,423,394.89 |
| Under-construction Projects |
3,122,586,955.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
338,954,502.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,000,080.89 |
| Deferred Income Tax Assets |
61,954,450.39 |
| Other Non-Current Assets |
939,759,304.48 |
| Sub-Total of Non-Current Assets |
9,424,610,080.64 |
| Total Assets |
13,949,755,542.31 |
| Short-Term Loans |
996,316,675.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
645,081,822.27 |
| Accounts Received In Advance |
514,863.28 |
| Employee Compensation Payable |
42,843,286.85 |
| Taxes Payable |
72,214,136.48 |
| Interest Payable |
-- |
| Dividend Payable |
10,637,405.01 |
| Other payables |
161,593,072.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
555,759,313.70 |
| Other Current Liabilities |
11,061,900.03 |
| Sub-Total of Current Liabilities |
2,591,209,333.70 |
| Long-term Loans |
3,325,084,920.34 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,725,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,702,785.33 |
| Other Non-Current Liabilities |
4,500,000.00 |
| Sub-Total of Non-Current Liabilities |
3,443,617,588.26 |
| Total Liabilities |
6,034,826,921.96 |
| Paid-In Capital(Or Share Stock) |
920,729,464.00 |
| Capital Surplus |
3,783,519,874.44 |
| Surplus Reserve |
202,808,496.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,814,447,217.13 |
| Minority Stockholder's Interest |
1,184,847,927.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,730,080,692.48 |
| Owner's Equity（Stockholder's Equity） |
7,914,928,620.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,949,755,542.31 |
